Publisher
Springer Science and Business Media LLC
Reference11 articles.
1. Kim TH, Jeong SY, Choi DH, Kim DY, Jung KH, Moon SH, et al. Lateral lymph node metastasis is a major cause of locoregional recurrence in rectal cancer treated with preoperative chemoradiotherapy and curative resection. Ann Surg Oncol. 2008;15(3):729–37.
2. Ogura A, Konishi T, Cunningham C, Garcia-Aguilar J, Iversen H, Toda S, et al. Neoadjuvant (chemo)radiotherapy with total mesorectal excision only is not sufficient to prevent lateral local recurrence in enlarged nodes: results of the multicenter lateral node study of patients with low cT3/4 rectal cancer. J Clin Oncol. 2019;37(1):33–43.
3. Sluckin TC, Hazen SJA, Horsthuis K, Beets-Tan RGH, Aalbers AGJ, Beets GL, et al. Evaluation of national surgical practice for lateral lymph nodes in rectal cancer in an untrained setting. Ann Surg Oncol. 2023. https://doi.org/10.1245/s10434-023-13460-0.
4. Hazen SM, Sluckin T, Beets G, Hompes R, Tanis P, Kusters M, et al. Current practices concerning the assessment and treatment of lateral lymph nodes in low rectal cancer: a survey among colorectal surgeons in the Netherlands. Acta Chir Belg. 2021;2021:1–9.
5. Konishi T, Kuroyanagi H, Oya M, Ueno M, Fujimoto Y, Akiyoshi T, et al. Multimedia article. Lateral lymph node dissection with preoperative chemoradiation for locally advanced lower rectal cancer through a laparoscopic approach. Surg Endosc. 2011;25(7):2358–9.